SEC 13F Intelligence

Corton Capital Inc. / PCRX

Corton Capital Inc.’s Pacira Biosciences Inc Position

Does Corton Capital Inc. own Pacira Biosciences Inc (PCRX)? Not currently — the last reported position was 12.6K shares worth $313,110 in Q1 2025; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$313,110
Q1 2025
Shares
12.6K
% of Portfolio
+1.04%
Quarters Held
3
position exited

Position History PCRX

Reported value by quarter
Q3 ’24: $306,433Q3 ’24Q4 ’24: $406,473Q4 ’24Q1 ’25: $313,110Q1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202512.6K$313,110+1.04%
Q4 202421.6K$406,473+0.23%
Q3 202420.4K$306,433+0.15%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Corton Capital Inc.’s full portfolio or all institutional holders of PCRX.